Overview
What is Transcelerate Biopharma Inc?
Transcelerate Biopharma Inc is a nonprofit organization based in West Conshohocken, Pennsylvania, dedicated to enhancing the global biopharmaceutical community's R&D of innovative therapies. Through collaborations, they identify, prioritize, design, and facilitate the implementation of solutions to improve the efficient, effective, and high-quality delivery of new medicines. With over 25 employees, Transcelerate Biopharma's initiatives include the Digital Data Flow (DDF) Initiative, Diversity of Participants in Clinical Trials Initiative, Modernizing Clinical Trial Conduct (MCTC) Initiative, Patient Experience (PE) Initiative, Site Qualification & Training (SQT) Initiative, Interpretation of Clinical Guidances & Regulations (IGR) Initiative, Modernization of Statistical Analytics (MOA) Initiative, Clinical Content & Reuse Initiative, and Privacy Methodology for Data Sharing Initiative. Their work spans various aspects of clinical trials, data sharing, and regulatory compliance to help biopharmaceutical companies bring new medicines to the market more efficiently.
Official website here: www.transceleratebiopharmainc.com
What are the reviews and ratings of this charity?
Transcelerate Biopharma Inc is not currently rated by Charity Navigator. The lack of a rating is due to the organization's non-registration as a 501(c)(3) nonprofit, which is necessary for Charity Navigator evaluation, rather than an indication of organizational performance. As a private entity, Transcelerate operates outside the scope of the standard metrics applied by Charity Navigator, such as Accountability and Finance, Leadership & Adaptability, Culture & Community, or Impact & Measurement.
The absence of financial and salary data further limits the ability to provide a comprehensive assessment of Transcelerate's management and financial practices. As a non-501(c)(3) organization, it does not benefit from tax-exempt status or the eligibility to receive tax-deductible contributions. However, its independence from larger networks of organizations suggests focused and potentially agile operations.
Without user reviews from GreatNonprofits, it is challenging to provide community feedback or client experiences related to Transcelerate Biopharma Inc. Organizations like Transcelerate typically contribute to industry-specific initiatives potentially beyond the general consumer philanthropic space, and this might explain the lack of public reviews.
This AI summary has been generated from information found on Charity Navigator.
Is Transcelerate Biopharma Inc legitimate?
Transcelerate Biopharma Inc is a legitimate nonprofit organization registered as a 501(c)(6) entity. Transcelerate Biopharma Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $1,740,969
Professional Fundraising Fees: $0
Other Salaries and Wages: $6,642,296
For more financial information, click here
Official website here: www.transceleratebiopharmainc.com
What is the mission statement of Transcelerate Biopharma Inc?
Transcelerate Biopharma Inc is a non-profit organization with a mission to improve global health by enhancing the research and development (R&D) of innovative new therapies. Through collaboration within the biopharmaceutical R&D community, Transcelerate identifies, prioritizes, designs, and facilitates the implementation of solutions that drive the efficient, effective, and high-quality delivery of new medicines. Membership in Transcelerate is open to biopharmaceutical companies with research and development operations.
Official website here: www.transceleratebiopharmainc.com
Who is the CEO of Transcelerate Biopharma Inc?
Janice Chang is the CEO of Transcelerate Biopharma Inc The CEO's salary of Transcelerate Biopharma Inc is $1,062,291 and their total compensation is $1,104,805.
Official website here: www.transceleratebiopharmainc.com
What is the revenue of Transcelerate Biopharma Inc?
Transcelerate Biopharma Inc's revenue in 2024 was $38,595,799.
Official website here: www.transceleratebiopharmainc.com
Who are the executives of Transcelerate Biopharma Inc and what are their salaries?
The average compensation at Transcelerate Biopharma Inc during 2024 was $254,038. There are 33 employees and 27 volunteers at Transcelerate Biopharma Inc.
Here are 34 key members and their salaries (Transcelerate Biopharma Inc's CEO's salary is $1,062,291 and their total compensation is $1,104,805):
- Compensation: $1,062,291
- Related: $0
- Other: $42,514
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $582,003
- Related: $0
- Other: $54,161
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $461,236
- Related: $0
- Other: $44,362
- Compensation: $397,818
- Related: $0
- Other: $47,267
- Compensation: $417,189
- Related: $0
- Other: $53,497
- Compensation: $395,823
- Related: $0
- Other: $33,953
- Compensation: $389,486
- Related: $0
- Other: $66,267
Official website here: www.transceleratebiopharmainc.com
Where can I find the form 990 for Transcelerate Biopharma Inc?
Transcelerate Biopharma Inc's most recent form 990 was submitted in 2024 and can be accessed here.
Official website here: www.transceleratebiopharmainc.com
Learn more at the official website: www.transceleratebiopharmainc.com
Mission Statement of Transcelerate Biopharma Inc
Transcelerate Biopharma Inc, a non-profit organization, is committed to enhancing the global biopharmaceutical community's research and development (R&D) of innovative new therapies. With a mission to collaborate across the industry, Transcelerate Biopharma aims to identify, prioritize, design, and facilitate the implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. By bringing together biopharmaceutical companies with research and development operations, Transcelerate Biopharma fosters a collaborative environment that accelerates the process of bringing groundbreaking therapies to the world. Together, members of Transcelerate Biopharma work towards improving health outcomes for people around the globe. Through their collective efforts, the organization identifies key challenges in the R&D process, designs and implements solutions, and facilitates their implementation to ensure the timely and efficient delivery of new medicines. Transcelerate Biopharma's collaborative approach creates a powerful network of industry experts, driving innovation and advancing the development of life-changing therapies.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Transcelerate Biopharma Inc. significantly impacts the global biopharmaceutical landscape by enhancing the research and development (R&D) processes for innovative therapies. By fostering collaboration among biopharmaceutical companies, Transcelerate identifies and implements solutions that promote efficient and high-quality delivery of new medicines.
In 2022, Transcelerate spearheaded several key initiatives. The Digital Data Flow (DDF) initiative, for instance, established foundational standards to facilitate the exchange of digital protocol data, ensuring better connectivity across disparate systems. This foundational work is vital for improving data integration and usability in clinical trials.
Furthermore, the organization prioritized diversity and inclusion in clinical trials. The Diversity of Participants in Clinical Trials initiative produced a comprehensive reference list and toolkit aimed at increasing the representation of racial and ethnic minorities, thus ensuring that clinical research inclusively reflects the patient population.
Transcelerate also made strides in modernizing clinical trial practices through the Modernizing Clinical Trial Conduct (MCTC) initiative, which provided insights into the future of clinical trials and offered resources for participant data return. Their efforts to streamline patient engagement through the Patient Experience initiative have empowered sponsors to utilize patient feedback more effectively in the development process.
The Clinical Data Sharing (CDS) team focused on improving data sharing practices, while the Pharmacovigilance initiatives introduced innovative methodologies to enhance drug safety monitoring. Overall, Transcelerate Biopharma Inc. is fundamentally transforming how biopharmaceutical R&D is conducted, aiming to improve medicine accessibility and health outcomes on a global scale.
This information is meant to be a general summary of Transcelerate Biopharma Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2024.
- Investment Income: $1,193,799
- Program Service Revenue: $37,402,000
- Gross Receipts: $38,595,799
Assets and Liabilities:
- Total Assets: $48,482,660
- Total Liabilities: $38,508,812
- Net Assets: $9,973,848
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
MEMBERSHIP DUES
Revenue
$37,402,000
Organization Details
Founding Year
2012
Phone
(484) 539-1230Principal Officer
Janice Chang
Main Address
300 CONSHOHOCKEN STATE ROAD 420, WEST CONSHOHOCKEN, PA, 19428
NTEE Category
Code: H99 - Medical research
If you are a representative of Transcelerate Biopharma Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.